These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 17292045)
21. The metabolomics of carotenoids in engineered cell factory. Liu GN; Zhu YH; Jiang JG Appl Microbiol Biotechnol; 2009 Jul; 83(6):989-99. PubMed ID: 19529930 [TBL] [Abstract][Full Text] [Related]
22. A metabolomics and proteomics study of the adaptation of Staphylococcus aureus to glucose starvation. Liebeke M; Dörries K; Zühlke D; Bernhardt J; Fuchs S; Pané-Farré J; Engelmann S; Völker U; Bode R; Dandekar T; Lindequist U; Hecker M; Lalk M Mol Biosyst; 2011 Apr; 7(4):1241-53. PubMed ID: 21327190 [TBL] [Abstract][Full Text] [Related]
23. The future is now. Comarow A; Healy B US News World Rep; 2003 Dec; 135(19):40-2, 44-6. PubMed ID: 14712603 [No Abstract] [Full Text] [Related]
24. Metabolomics: a new era in cardiology? Mercuro G; Bassareo PP; Deidda M; Cadeddu C; Barberini L; Atzori L J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):800-5. PubMed ID: 21934525 [TBL] [Abstract][Full Text] [Related]
26. A biological approach to computational models of proteomic networks. Janes KA; Lauffenburger DA Curr Opin Chem Biol; 2006 Feb; 10(1):73-80. PubMed ID: 16406679 [TBL] [Abstract][Full Text] [Related]
27. Tumor cell metabolism: the marriage of molecular genetics and proteomics with cellular intermediary metabolism; proceed with caution! Costello LC; Franklin RB Mol Cancer; 2006 Nov; 5():59. PubMed ID: 17090311 [TBL] [Abstract][Full Text] [Related]
28. Dietary isoflavones in the prevention of cardiovascular disease--a molecular perspective. Rimbach G; Boesch-Saadatmandi C; Frank J; Fuchs D; Wenzel U; Daniel H; Hall WL; Weinberg PD Food Chem Toxicol; 2008 Apr; 46(4):1308-19. PubMed ID: 17689850 [TBL] [Abstract][Full Text] [Related]
32. [Proteomics in cardiology]. Pinet F Arch Mal Coeur Vaiss; 2007 Jan; 100(1):47-51. PubMed ID: 17405554 [TBL] [Abstract][Full Text] [Related]
33. Biomarkers in cardiovascular diseases: how can the "-omics" revolution be applicable at the bedside. Introduction. Tang WH Prog Cardiovasc Dis; 2012; 55(1):1-2. PubMed ID: 22824104 [No Abstract] [Full Text] [Related]
34. Proteomic applications to elucidate bacterial aromatic hydrocarbon metabolic pathways. Kim SJ; Kweon O; Cerniglia CE Curr Opin Microbiol; 2009 Jun; 12(3):301-9. PubMed ID: 19414279 [TBL] [Abstract][Full Text] [Related]
35. Genomics in cardiac metabolism. Samuel JL; Schaub MC; Zaugg M; Mamas M; Dunn WB; Swynghedauw B Cardiovasc Res; 2008 Jul; 79(2):218-27. PubMed ID: 18326557 [TBL] [Abstract][Full Text] [Related]
36. Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model. Tong A; Wu L; Lin Q; Lau QC; Zhao X; Li J; Chen P; Chen L; Tang H; Huang C; Wei YQ Proteomics; 2008 May; 8(10):2012-23. PubMed ID: 18491315 [TBL] [Abstract][Full Text] [Related]
37. Functional proteomics to identify critical proteins in signal transduction pathways. Yan GR; He QY Amino Acids; 2008 Aug; 35(2):267-74. PubMed ID: 17704892 [TBL] [Abstract][Full Text] [Related]
38. Proteomics- and metabolomics-based neonatal diagnostics in assessing and managing the critically ill neonate. Spitzer AR; Chace D Clin Perinatol; 2008 Dec; 35(4):695-716, vi. PubMed ID: 19026335 [TBL] [Abstract][Full Text] [Related]